Original Article Plastic Surgery Quality Improvement Sports Medicine
Rethinking glycaemic control in adults with type 2 diabetes: the role of point-of-care ultrasound

Rethinking glycaemic control in adults with type 2 diabetes: the role of point-of-care ultrasound

Authors

Adam Kim

Adam Kim

Karolinska University Hospital, Malawi

Corresponding

Published

October 4, 2024

Paper ID

PAP-000191

Status

Published

DOI

10.65712/tmj.test000449

Rethinking glycaemic control in adults with type 2 diabetes: the role of point-of-care ultrasound

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Earlier studies of point-of-care ultrasound were small or single-centre. Methods: Eligible participants were adults with type 2 diabetes. Results: Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups. Conclusion: These findings suggest that point-of-care ultrasound is associated with better glycaemic control in adults with type 2 diabetes.

Introduction

Guidelines make only a weak recommendation on point-of-care ultrasound. Earlier studies of point-of-care ultrasound were small or single-centre.

glycaemic control remains a leading cause of avoidable harm among adults with type 2 diabetes. Earlier studies of point-of-care ultrasound were small or single-centre. The cost of glycaemic control to health systems is substantial.

Guidelines make only a weak recommendation on point-of-care ultrasound. The cost of glycaemic control to health systems is substantial.

Guidelines make only a weak recommendation on point-of-care ultrasound. The cost of glycaemic control to health systems is substantial.

Materials and Methods

We conducted a quality-improvement audit across 12 centres between 2017 and 2024. Analyses were adjusted for age, sex and baseline severity.

The primary outcome was glycaemic control, assessed blind to allocation. We conducted a quality-improvement audit across 2 centres between 2015 and 2023.

Results

2074 participants were included (median age 28 years). 2878 participants were included (median age 70 years). Serious adverse events were rare and similar between groups.

Effects were consistent across prespecified subgroups. 777 participants were included (median age 31 years).

GroupnEventsRate %OR95% CI
Intervention7441128.50.810.33–1.31
Control80410623.00.670.42–1.21
Female6506016.20.600.52–1.28
TABLE 1: Secondary outcomes
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Distribution of glycaemic control
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.

The adjusted odds ratio was 0.88 (95% CI 0.47 to 0.96). The adjusted odds ratio was 0.61 (95% CI 0.45 to 0.90).

The adjusted odds ratio was 0.39 (95% CI 0.33 to 0.72). glycaemic control occurred in 20% of the intervention group versus 31% of controls. Serious adverse events were rare and similar between groups.

Discussion

Implementation will depend on staffing, cost and local protocols. These findings suggest that point-of-care ultrasound is associated with better glycaemic control in adults with type 2 diabetes. Residual confounding cannot be excluded.

Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.

Conclusions

Point-of-care ultrasound may be offered for adults with type 2 diabetes to improve glycaemic control.

References

1. Nakamura E, Ibrahim J, et al. Low-dose aspirin and falls. N Engl J Med. 2018;212(9):517-1699.

2. Novak V, Nakamura G, et al. Delayed cord clamping and glycaemic control. BMC Med. 2018;155(1):159-1006.

3. Nakamura C, Nakamura L, et al. Early mobilisation and surgical site infection. N Engl J Med. 2022;52(4):6-1657.

4. Patel D, Dubois O, et al. Tranexamic acid and emergency department revisits. Ann Intern Med. 2018;299(3):747-1655.

5. Dubois A, Rahman E, et al. Point-of-care ultrasound and emergency department revisits. BMC Med. 2009;317(3):275-1759.

6. Zhang S, Andersen D, et al. Telemedicine follow-up and acute kidney injury. JAMA. 2008;81(4):125-1098.

7. Schmidt B, Farouk I, et al. Point-of-care ultrasound and surgical site infection. N Engl J Med. 2014;296(5):92-1528.

8. Moreau C, Moreau S, et al. Frailty screening and time to diagnosis. BMC Med. 2010;178(9):538-1267.

9. Ahmed I, Kim L, et al. SGLT2 inhibitors and ventilator-free days. Diabetes Care. 2014;21(9):730-1613.

Appendices

The statistical analysis plan is in the online supplement.